[Federal Register: April 1, 2004 (Volume 69, Number 63)]
[Notices]
[Page 17159-17163]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01ap04-84]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Health Organization Strategies To Provide Information
and Education for Patients, Their Family Members, Friends, and
Caregivers With Respect to Hematologic Cancers
Announcement Type: New.
Funding Opportunity Number: 04159.
Catalog of Federal Domestic Assistance Number: 93.283.
Key Dates:
Letter of Intent Deadline: May 3, 2004.
Application Deadline: May 28, 2004.
I. Funding Opportunity Description
Authority: This program is authorized under sections 301(a),
317(k)(2) of the Public Health Service Act, [42 U.S.C. 241 (a)and
247b(k)(2)], as amended.
Purpose: The purpose of the program is to announce the availability
of fiscal year 2004 funds for cooperative agreements for national
health organization strategies to provide information and education for
patients, their family members, friends, and caregivers with respect to
hematologic cancers. This program will assist national health
organizations in the development and implementation of strategies to
promote and disseminate information and education, and to increase
awareness of support services for patients, their family members,
friends, and caregivers with respect to hematologic cancers,
particularly leukemia, lymphoma, and/or multiple myeloma.
This program addresses the ``Healthy People 2010'' focus area of
cancer, specifically Chapter 3, Goals 3-1 (Reduce the overall cancer
death rate) and Goals 3-15 (Increase the proportion of cancer survivors
who are living 5 years or longer after diagnosis).
Measurable outcomes of the program will be in alignment with the
following performance goal for the Centers for Disease Control and
Prevention (CDC): Increase the proportion of cancer of hematologic
cancer survivors, particularly leukemia, lymphoma, and/or multiple
myeloma who are living five years or longer after diagnosis through
effective individual, community, and health care provider health
promotion strategies, information dissemination, and education.
This project includes developing partnerships to facilitate the
exchange of previously developed and tested hematologic cancer
information and education resources (existing or newly developed) among
a variety of public agencies and national health organizations. This
program may also include efforts to develop and test new hematologic
cancer information and education resources for individuals who may be
underserved, uninsured or underinsured, or of racial/ethnic minorities
if a need can be demonstrated and appropriate materials are not
available.
Activities: Awardee activities for this program include development
of programs, strategies, and partnerships designed to promote and
disseminate previously effective developed and tested information and
education resources for patients, their family members, friends, and
caregivers with respect to hematologic cancers, particularly of
leukemia, lymphoma, and/or multiple myeloma, as follows:
Develop and test new hematologic cancer
information and education resources for individuals who may be
underserved, uninsured or underinsured, or of racial/ethnic minorities
if a need can be demonstrated and no materials currently exist pending
CDC approval. Performance will be measured by the extent to which the
applicant reaches hematologic cancer patients, their family members,
friends, and caregivers.
Develop and carry out strategies to increase
awareness of patient support services for hematologic cancer patients.
Performance will be measured by the extent to which implemented
strategies increase awareness of services.
Establish specific, measurable, and realistic
short-term (one year) and long-term (three year) program objectives
consistent with the purpose of this program announcement for the
accomplishment of program activities.
Performance will be measured based upon the extent to which
objectives are realistic, time-phased, and achievable.
Identify and hire appropriate staff.
Performance will be measured by the extent to which the
organization has hired qualified staff and supported them with
resources to accomplish the goals and objectives proposed.
Establish partnerships with other federal
agencies, such as National Cancer Institute (NCI) and Health Resources
and Services Administration (HRSA), Comprehensive Cancer Control (CCC)
programs in state health departments, American Indian/Alaska Native
organizations, U.S. territories, the District of Columbia, and/or other
national health organizations to implement hematologic cancer education
activities to ensure effective and efficient implementation of the
program strategies.
Performance will be measured based on the extent to which the
program establishes and uses new partnerships in developing and
disseminating hematologic cancer education activities.
Participate in a minimum of two CDC or other
hematologic cancer partner meetings per year to facilitate the
accomplishment of proposed objectives. Performance will be measured by
the extent to which the organization participates in or facilitates at
least two meetings per year (e.g. annual, regional, CDC-sponsored,
etc.) to either gain information or to educate partners.
Evaluate achievement of each goal and objective
through a well-designed evaluation plan. Effectiveness will be measured
based on the development and use of objective, quantitative measures to
demonstrate the accomplishment of program goals, objectives, and
intended outcomes.
Disseminate information regarding organization
achievements and activities to hematologic cancer patients, their
family members, friends, and caregivers.
Performance will be measured by the activities undertaken to
disseminate strategies and share information with partners.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC Activities for this program are as follows:
Collaborate with recipients in the development,
implementation, evaluation, and dissemination of program strategies
designed to provide information and education, and to increase
awareness of support services for patients, their family members,
friends, and caregivers with respect to hematologic cancers,
particularly leukemia, lymphoma, and/or multiple myeloma.
Collaborate with recipients in the development
of information dissemination approaches that relate to the purpose of
this program announcement.
Facilitate the exchange of program information,
technical assistance, and the development of partnerships between
recipients funded under this program announcement and federal
[[Page 17160]]
agencies, community organizations, health departments, and other
appropriate partners. Collaborate with recipients to develop meeting
agendas including identifying speakers and presenters.
Review and approve all strategies to develop and
test new materials to ensure that there is a clear demonstrated need
for a particular population.
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year Funds: 2004.
Approximate Total Funding: $3,000,000.
Approximate Number of Awards: 5-6.
Approximate Average Award: $500,000.
(This amount is for the first 12-month budget period, and includes
both direct and indirect costs.)
Floor of Award Range: None.
Ceiling of Award Range: $500,000 (This ceiling is for the first 12-
month budget period.)
Anticipated Award Date: August 16, 2004.
Budget Period Length: 12 months.
Project Period Length: 3 years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
Applications may be submitted by public and private nonprofit and
for profit, such as:
Public nonprofit organizations
Private nonprofit organizations
For profit organizations
Applications may be submitted by national health organizations that
have the capacity and ability to conduct nationwide programmatic
activities related to promoting hematologic cancer education and
information dissemination on support services that serve a large number
of hematologic cancer patients. Applicants must demonstrate the ability
to implement programs related to hematologic cancers. Due to the fact
that this program is intended to serve the entire nation, to be
eligible, national organizations must serve as an umbrella organization
for their constituents (having regional or local chapters or
memberships), implementing activities in 25 or more states.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you request a funding amount greater than the ceiling of the
award range, your application will be considered non-responsive, and
will not be entered into the review process. You will be notified that
your application did not meet the submission requirements.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
IV. Application and Submission Information
IV.1. Address To Request Application Package
To apply for this funding opportunity use application form PHS
5161. Application forms and instructions are available on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Letter of Intent (LOI):
Your LOI must be written in the following format:
Maximum number of pages: 2
Font size: 12-point unreduced
Double spaced
Paper size: 8.5 by 11 inches
Page margin size: One inch
Printed only on one side of page
Written in plain language, avoid jargon
Your LOI must contain your organization's name, address and contact
information.
Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 35. If your narrative
exceeds the page limit, only the first pages which are within the page
limit will be reviewed.
Font size: 12 point unreduced
Paper size: 8.5 by 11 inches
Page margin size: One inch
Double spaced
Printed only on one side of page
Held together only by rubber bands or metal clips;
not bound in any other way.
Your narrative should address activities to be conducted over the
entire three year project period, and must include the following items
in the order listed:
Executive Summary: The applicant should provide a clear, concise 1-
2 page written summary to include:
1. Proposed strategies to promote and disseminate information and
education, and to increase awareness of support services for patients,
their family members, friends, and caregivers with respect to
hematologic cancers.
2. Statement of capability to conduct the proposed strategies.
3. Requested amount of funding.
Capacity: Describe the applicant's history and experience with
program activities or any services provided to people affected by
hematologic cancers, and the rationale for use of previously conducted
or newly developed innovative strategies to enhance the delivery of
education, information, or support services to patients with
hematologic cancers, particularly leukemia, lymphoma, and/or multiple
myeloma.
Work Plan: The applicant should provide a detailed work plan for
the first year that describes how the proposed activities will be
conducted. The work plan should include the following:
1. Objectives: Specific, realistic, and time-phased, measurable,
short-term (one year) and long-term (three year) objectives consistent
with the intent of this program announcement.
2. Activities: Specific activities and strategies that will be
undertaken to achieve each of the proposed short-term objectives during
the budget period.
3. Time Line: A time line for assessing progress in meeting
objectives.
4. Staff Responsibility: Staff responsible for completion of
activities. Include the level of effort and allocation of time for each
project activity by staff position.
5. Program Evaluation: How activities and their impact will be
evaluated, including indicators of program success.
Grantees may choose to use the attached work plan format to present
this information (See Attachment A of this announcement as posted on
the CDC Web site.)
Project Management:
1. Describe the organization's structure and function, size,
national membership substructure, activities on a national level, and
methods of routine communication with members.
[[Page 17161]]
2. Describe each current or proposed staff position for this
program by job title, function, education and experience, general
duties, and activities with which that position will be involved.
Collaborative Activities: Describe past and proposed collaborative
working partnerships with providers, community groups or others who
serve or have established linkages with patients with hematologic
cancers.
Budget and Justification: Provide a detailed line item budget and
narrative justification of all operating expenses consistent with the
proposed objectives and planned activities. Each budget item should be
clearly related to a stated activity.
Participation in CDC sponsored training, workshops, or meetings is
essential to the effective implementation of hematologic cancer
education and information activities. Travel funds should be budgeted
for the following meetings:
Three to five persons to Atlanta, Georgia to discuss program
implementation progress (reverse site visit) and for consultation and
technical assistance (two days, one trip per year.)
Up to two additional two-person trips to Atlanta, or other
destinations to attend or assist with national workgroups, task forces,
or committees (one to three days.)
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit, but should not exceed 20 pages. This additional information
includes:
Curriculum vitae
Job descriptions
Organizational charts
Work plan
Any other supporting documentation
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-
5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm
If your application form does not have a
DUNS number field, please write your DUNS number at the top of the
first page of your application, and/or include your DUNS number in your
application cover letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
LOI Deadline Date: May 3, 2004.
CDC requests that you send a LOI if you intend to apply for this
program. Although the LOI is not required, not binding, and does not
enter into the review of your subsequent application, the LOI will be
used to gauge the level of interest in this program, and to allow CDC
to plan the application review.
Application Deadline Date: May 28, 2004.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. eastern time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
This announcement is the definitive guide on application submission
address and deadline. It supersedes information provided in the
application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that your application did not meet the
submission requirements.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for applications to be
processed and logged.
IV. 4. Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV. 5. Funding Restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Funds may be used to support personnel and to
purchase supplies and services directly related to program activities
consistent with the scope of this announcement. While the purchase of
equipment is discouraged, it will be considered for approval if
justified on the basis of being essential to the program and not
available from another source.
Funds provided under this announcement are not
to be used to conduct research.
Funds may not be used for the purchase or lease
of land or buildings, construction of facilities, renovation of
existing space, or the delivery of clinical and therapeutic services,
personal health services, medications, rehabilitation or other costs
associated with screening or treatment for cancer.
Funds provided under this announcement may not
be used for the endorsement or promotion of any drugs, health products,
or medical supplies and equipment.
Applicants are encouraged to maximize the public
health benefit of CDC funding. Recipients have the ability to redirect
up to 25 percent of the total approved budget to achieve stated goals
and objectives within the scope of the award, except from categories
that require prior approval such as contracts or change in scope or key
personnel. A list of required prior approval actions will be included
in the Notice of Grant Award.
Awards will not allow reimbursement of pre-award
costs.
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement should be less than 12
months of age.
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
IV.6. Other Submission Requirements
LOI Submission Address: Submit your LOI by express mail, delivery
service, fax, or E-mail to: Christine Dauer, Public Health Advisor,
Centers for Disease Control and Prevention, National Center for Chronic
Disease Prevention and Health Promotion, Division of Cancer Prevention
and Control, Office of the Director, 4770 Buford Highway, NE., Mailstop
K-52, Atlanta, GA 30341-3724, Telephone:
[[Page 17162]]
(770) 488-3056, Fax: (770) 488-4760, E-mail: CDauer@cdc.gov.
Application Submission Address: Submit the original and two hard
copies of your application by mail or express delivery service to:
Technical Information Management-PA 04159, CDC Procurement and
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.
V. Application Review Information
V.1. Criteria
You are required to provide measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the cooperative agreement. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
Evaluation Criteria (100 Points Total)
1. Work Plan (50 Points)
Objectives
Are short-term (one year) and long-term (three year) objectives
specific, time-phased, measurable, realistic, related to identified
needs and consistent with the purpose of this program announcement?
Activities
Does the applicant's plan for achieving the proposed activities
appear realistic and feasible and relate to the programmatic
requirements and purposes of this program announcement?
Evaluation Plan
Does the proposed evaluation plan address progress toward meeting
goals and objectives, describe indicators of program success, and
appear to be reasonable and feasible?
2. Project Management (25 Points)
Does proposed staffing, organizational structure, staff experience
and background, training needs or plan, job descriptions and curricula
vitae for both proposed and current staff indicate past experience in
carrying out similar programs and the ability to carry out the purposes
of the current program? Does the applicant demonstrate ability to
manage the project, including lines of communication, and
organizational support? Can the activities described reasonably be
accomplished? What is the relationship of the activities to the
expected outcomes?
3. Collaborative Activities (15 Points)
Does the applicant describe clear and complete plans to develop
relationships with or engage other organizations, agencies, or partners
to provide for complementary or supplementary activities and resources?
4. Capacity (10 Points)
Does the applicant demonstrate the capacity and ability of the
organization to implement proposed activities including,
infrastructure, relationship to intended audience, and experience with
partners?
5. Budget and Justification (Not Scored)
Is the budget well-justified, reasonable, and consistent with the
purpose and activities of the program?
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by the National
Center for Chronic Disease (NCCD), Division of Cancer Prevention and
Control (DCPC). Incomplete applications and applications that are non-
responsive to the eligibility criteria will not advance through the
review process. Applicants will be notified that their application did
not meet submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above.
V.3. Anticipated Announcement and Award Dates
August 16, 2004.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR Part 74 and Part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-8 Public Health System Reporting
Requirements.
AR-10 Smoke-Free Workplace Requirements.
AR-11 Healthy People 2010.
AR-12 Lobbying Restrictions.
AR-14 Accounting System Requirements.
AR-25 Release and Sharing of Data.
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
VI.3. Reporting Requirements
You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, no less than 90 days before the end of
the budget period. The progress report will serve as your non-competing
continuation application, and must contain the following elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Additional Requested Information.
f. Measures of Effectiveness.
2. Financial status report, no more than 90 days after the end of
the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
For general questions about this announcement, contact: Technical
Information Management Section, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
For program technical assistance, contact: Christine Dauer, Public
Health Advisor, Centers for Disease Control and Prevention, National
Center for Chronic Disease Prevention and Health Promotion, Division of
Cancer Prevention and Control, Office of the Director.
For mail service: 4770 Buford Highway, NE., Mailstop K-52, Atlanta,
[[Page 17163]]
GA 30341-3724, Telephone: (770) 488-3056, Fax: (770) 488-4760, E-mail:
CDauer@cdc.gov.
For financial, grants management, or budget assistance, contact:
Angela Webb, Grants Management Specialist, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-
2784, E-mail: aqw6@cdc.gov.
VIII. Other Information
Technical Assistance Workshop
Technical assistance will be available for potential applicants
during a workshop scheduled for April 26, 2004 in Atlanta, GA at the
Atlanta Airport Executive Conference Center. The purpose of the
workshop is to help potential applicants understand the scope and
intent of the program announcement, Public Health Service funding
policies, and application and review procedures. Participation in the
workshop is not mandatory. Applicants who wish to attend the workshop
will be responsible for their own travel and lodging expenses.
Applicants who plan to attend the workshop must RSVP to Christine Dauer
at e-mail CDauer@cdc.gov by no later than April 18, 2004.
Dated: March 26, 2004.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-7306 Filed 3-31-04; 8:45 am]
BILLING CODE 4163-18-P